Related Experiment Video
Updated: Jan 26, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Emerging role of PI3K/AKT in tumor-related epigenetic regulation
Qi Yang1, Wei Jiang2, Peng Hou1
1Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Abstract:
Epigenetic alterations, along with genetic alterations, have long been regarded as the most important mechanism participating in carcinogenesis. DNA methylation, histone modifications, and RNA-mediated regulation are involved in many cellular processes that are essential to cancer initiation and progression. A plethora of chromatin-associated proteins and modifying proteins take control of these processes and they are under the modulation of signaling pathways. The phosphatidylinositol 3-kinase (PI3K)/AKT pathway (PI3K/AKT) is in manage of multiple biological processes and is frequently aberrantly activated in human cancers. Increasing evidence has demonstrated that critical epigenetic modifiers are directly or indirectly modulated by PI3K/AKT signaling, and participate in oncogenicity of PI3K cascade in cancers. In this review, we revisit the mechanism of the PI3K/AKT signaling pathway modulating epigenetic reprogramming in cancer and attempt to establish the connection between PI3K/AKT cascade and the epigenome.
Insights
The phosphatidylinositol 3-kinase (PI3K)/AKT pathway influences cancer development by altering epigenetic mechanisms like DNA methylation and histone modifications. This review explores how PI3K/AKT signaling impacts cancer epigenetics.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Epigenetic alterations are crucial in cancer initiation and progression, alongside genetic changes.
- Key epigenetic mechanisms include DNA methylation, histone modifications, and RNA-mediated regulation.
- These processes are controlled by chromatin-associated proteins and influenced by signaling pathways.
Purpose of the Study:
- To review how the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway modulates epigenetic reprogramming in cancer.
- To establish the link between the PI3K/AKT cascade and the cancer epigenome.
Main Methods:
- Literature review of studies on PI3K/AKT signaling and epigenetic modifiers in cancer.
- Analysis of mechanisms by which PI3K/AKT influences DNA methylation, histone modifications, and RNA regulation.
- Examination of the role of these interactions in cancer initiation and progression.
Main Results:
- The PI3K/AKT pathway is frequently activated in human cancers and regulates multiple biological processes.
- Evidence shows PI3K/AKT signaling directly or indirectly modulates critical epigenetic modifiers.
- These modulations contribute to the oncogenic functions of the PI3K/AKT pathway in various cancers.
Conclusions:
- The PI3K/AKT pathway plays a significant role in cancer development through epigenetic reprogramming.
- Understanding the interplay between PI3K/AKT signaling and the epigenome is vital for cancer research.
- Targeting this crosstalk may offer novel therapeutic strategies for cancer treatment.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
PI3K/mTOR/AKT Signaling Pathway
Emerging Adulthood
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

